Related Experiment Video
Updated: Aug 16, 2026
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Retroviral expression screening of oncogenes in pancreatic ductal carcinoma
Hiroyuki Kisanuki1, Young Lim Choi, Tomoaki Wada
1Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan.
Abstract:
Pancreatic ductal carcinoma (PDC) remains one of the most intractable malignancies in humans. In order to clarify the molecular events underlying the carcinogenesis in PDC, we constructed a retroviral cDNA expression library from a PDC cell line, and used it to screen transforming genes in PDC by a focus formation assay with mouse 3T3 fibroblasts. We could obtain a total of 30 transformed cell foci in the screening, and one of the cDNA inserts harvested from such cell clones turned out to encode a wild-type human ARAF1. Unexpectedly, a long terminal repeat-driven overexpression of ARAF1 mRNA was confirmed to induce transformed foci in fibroblasts. The oncogenic potential of ARAF1 was examined by injecting the transformed fibroblasts into athymic nude mice. Importantly, ARAF1 mRNA was highly expressed in pancreatic ductal cell specimens purified from patients with PDC. These results have unveiled the transforming potential of ARAF1 protein, and also suggest that quantity of intracellular ARAF1 may be important in carcinogenesis of various human cancers.
Insights
Overexpression of ARAF1, a gene involved in cell signaling, can cause pancreatic ductal carcinoma (PDC) by transforming cells. High ARAF1 levels in PDC patients suggest its role in cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Genetics
Background:
- Pancreatic ductal carcinoma (PDC) is a highly lethal human malignancy.
- Understanding the molecular drivers of PDC is crucial for developing effective therapies.
Purpose of the Study:
- To identify genes involved in pancreatic ductal carcinoma (PDC) carcinogenesis.
- To investigate the transforming potential of identified genes in vitro and in vivo.
Main Methods:
- Construction of a retroviral cDNA expression library from a PDC cell line.
- Screening for transforming genes using focus formation assays with mouse 3T3 fibroblasts.
- Analysis of ARAF1 mRNA expression in PDC patient samples.
Main Results:
- A wild-type human ARAF1 gene was identified as a potential transforming gene.
- Overexpression of ARAF1 mRNA induced transformed foci in fibroblasts.
- ARAF1 mRNA was significantly upregulated in pancreatic ductal cell specimens from PDC patients.
Conclusions:
- The ARAF1 protein possesses transforming potential, contributing to oncogenesis.
- Intracellular ARAF1 levels may play a significant role in the development of various human cancers, including PDC.
